EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones

Miao Li, Qiurong Chang, Ye Luo, Jiaping Pan, Ye Hu, Binya Liu, Mengmeng Ma, Qiaoling Wang, Yi Guo, Qian Wang

Frontiers in Cell and Developmental Biology · 30.05.2024 · 12

DOI: 10.3389/fcell.2024.1384233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 30.05.2024. Verfasst von Miao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome (PCOS) is characterized by excess androgens, ovulatory dysfunction, and polycystic ovaries. The mechanisms underlying ovulatory and metabolic disorders in PCOS remain elusive, hampering therapeutic development. Enhanced metabolic health correlates with increased microbiota gene content and microbial diversity. We aimed to explore the impact of gut microbiota and serum steroids on PCOS regulation associated with androgen excess.

Methods

The fecal samples of patients with hyperandrogenic PCOS ( n = 14) and control group with PCOS ( n = 14) were analyzed by 16S rRNA gene sequencing. The peripheral venous blood of all subjects was collected to detect serum hormones. The association between gut microbiota and serum hormones was analyzed with the R language.

Results

Our findings reveal that the hyperandrogenic PCOS group exhibits lower richness and diversity of gut microbiota compared to the control group. Characteristic genera in PCOS patients with hyperandrogenism include Bifidobacterium, Enterobacteriaceae_unclassified, Streptococcus, Saccharimonadaceae, Enterococcus , and Eubacterium_nodatum_group . Five hormones, including 5β-androsterone, deoxycorticosterone, corticosterone, 11-dehydrocorticosterone, and cortexolone, emerge as potential serum biomarkers for identifying patients with hyperandrogenic-PCOS (HA-PCOS). Furthermore, a lower vitamin D3 level may act as a susceptibility factor, suggesting that vitamin D3 supplementation could serve as a potential intervention for PCOS with hyperandrogenism.

Conclusion

Specific fecal microbiota and serum steroids may be used as characteristic markers for clinical diagnosis of hyperandrogenic-PCOS. This research enhances our understanding of the intricate interplay among hormones, gut microbiota, and hyperandrogenemia in patients with PCOS.

Schlagwörter

Stichwörter der Autor:innen

PCOShyperandrogenemiametabolismmicrobiotaserum hormones

Autor:innen und Institutionen

  • Center for Reproductive Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Research and Education, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

Zitieren

APA

Li, M., Chang, Q., Luo, Y., Pan, J., Hu, Y., Liu, B., Ma, M., Wang, Q., Guo, Y., & Wang, Q. (2024). The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1384233

Vancouver

Li M, Chang Q, Luo Y, Pan J, Hu Y, Liu B, et al. The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1384233

BibTeX
@article{Li2024,
  author = {Li, Miao and Chang, Qiurong and Luo, Ye and Pan, Jiaping and Hu, Ye and Liu, Binya and Ma, Mengmeng and Wang, Qiaoling and Guo, Yi and Wang, Qian},
  title = {The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1384233}
}
Kostenlos starten →